Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2025-05-12 | 2025-04-03 |
| Drug Identification Number | 02392453 | 02392453 |
| Brand name | HEPARIN SODIUM INJECTION, USP | HEPARIN SODIUM INJECTION, USP |
| Common or Proper name | HEPARIN SODIUM INJECTION, USP | HEPARIN SODIUM INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | HEPARIN SODIUM | HEPARIN SODIUM |
| Strength(s) | 10000UNIT | 10000UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 0.5mL | 0.5mL |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2025-04-30 | 2025-04-30 |
| Estimated end date | 2025-05-22 | 2025-06-02 |
| Actual end date | 2025-05-22 | |
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada is pleased to advise that this product will be made available earlier than originally communicated. It will be available at Ontario distribution centres by May 22, 2025, and at all other distribution centres by May 26, 2025 | Further, we will be encountering a supply interruption on our Heparin Sodium Injection, USP 10 000 USP units/mL SD Vial 0.5 mL effective April 30, 2025, until June 2, 2025. |
| Health Canada comments |